ISBT's flagship international congress, covering the full transfusion chain — donor management, component preparation, immunohematology, storage, clinical transfusion — plus cell and gene therapy alongside co-host JSTMCT. The 2028 edition returns the congress to Japan after roughly 19 years and is expected to draw about 4,500 on-site delegates, of which around 3,500 travel from outside Japan.
This is where the science and standards behind blood-product cold chains are set and revised — temperature requirements, shelf life and quality of red cells, platelets, plasma, and increasingly cryopreserved cell therapies. ISBT working-party outputs and new evidence on component storage and transport surface here, feeding the guidance that downstream blood cold chains have to comply with.
ISBT working parties, blood service and blood bank directors, transfusion medicine physicians, component-processing and quality/regulatory specialists, and academic researchers, plus vendors of blood-bank refrigeration and cold storage equipment. It is a predominantly international scientific and clinical audience rather than a freight or logistics trade crowd.
Be the first to raise your hand.